Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping
Clinical trial NCT05670730 · COMPLETED
Trial details
- NCT number
- NCT05670730
- Sponsor
- Avidity Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2024-11-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.